Prophylactic Treatment of Intestinal Ischemia-Reperfusion Injury Reduces Mucosal Damage and Improves Intestinal...

Area of Science:

• Gastroenterology
• Pharmacology
• Surgical Research

Background:

• Intestinal ischemia-reperfusion injury (i-IRI) causes local and systemic damage due to oxidative and inflammatory molecules released upon reperfusion.
• Understanding i-IRI mechanisms is crucial for developing effective therapeutic strategies.

Purpose of the Study:

• To evaluate the efficacy of curcumin, dexmedetomidine, and α-tocopherol in preventing or reversing local and systemic damage caused by i-IRI.
• To assess the impact of these compounds on histological injury and intestinal absorptive capacity.

Main Methods:

• i-IRI was induced in rats by superior mesenteric artery occlusion followed by reperfusion.
• Animals were treated with curcumin, α-tocopherol, or dexmedetomidine (DEX5, DEX20).
• Histological injury, intestinal absorption (D-xylose test), and serum markers were evaluated.

Main Results:

• All tested compounds significantly reduced histological injury degree (HID).
• α-tocopherol showed the greatest reduction in HID.
• Dexmedetomidine uniquely restored intestinal absorption to levels comparable to healthy controls.
• Only dexmedetomidine significantly reduced urea and creatinine levels.

Conclusions:

• Curcumin, α-tocopherol, and dexmedetomidine demonstrate protective effects against i-IRI.
• α-tocopherol is highly effective in mitigating histological damage.
• Dexmedetomidine offers significant benefits in both reducing injury and restoring intestinal function.